Insider · CIK 0001551966
Robert Lorne Hopfner
Files at INZY (Inozyme Pharma, Inc.), RLYB (Rallybio Corp), EVMN (Evommune, Inc.). First filing Dec 22, 2025, latest Dec 22, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EVMN: Evommune, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | EVMN Evommune, Inc. | POpen-market purchase Common Stockindirect: By Trust | +1,000 | $17.35 | $17k | 4,026 | Dec 22, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Common Stockindirect: By Trust | +3,026 | - | - | 3,026 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Common Stockindirect: By NFLS Delta III Limited | +1,441,032 | - | - | 1,441,032 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Common Stockindirect: By Pivotal bioVenture Partners Fund I, L.P. | +1,632,441 | - | - | 1,632,441 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Common Stockindirect: By Pivotal bioVenture Partners Fund II, L.P. | +294,502 | - | - | 294,502 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series Seed Preferred Stockderivativeindirect: By Trust | -25,790 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series Seed Preferred Stockderivativeindirect: By NFLS Delta III Limited | -7,145,647 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series Seed Preferred Stockderivativeindirect: By Pivotal bioVenture Partners Fund I, L.P. | -3,572,816 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series A Preferred Stockderivativeindirect: By NFLS Delta III Limited | -2,582,243 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series A Preferred Stockderivativeindirect: By Pivotal bioVenture Partners Fund I, L.P. | -7,230,283 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series B Preferred Stockderivativeindirect: By NFLS Delta III Limited | -1,895,260 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series B Preferred Stockderivativeindirect: By Pivotal bioVenture Partners Fund I, L.P. | -2,104,740 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series C Preferred Stockderivativeindirect: By NFLS Delta III Limited | -313,571 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series C Preferred Stockderivativeindirect: By Pivotal bioVenture Partners Fund I, L.P. | -313,571 | - | - | 0 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series C Preferred Stockderivativeindirect: By Pivotal bioVenture Partners Fund II, L.P. | -2,508,575 | - | - | 0 | Nov 12, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | UTender of shares Common Stockindirect: By Pivotal | -2,923,110 | $4.00 | $12M | 0 | Jul 3, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | UTender of shares Common Stockindirect: By Pivotal | -1,571,741 | $4.00 | $6.3M | 0 | Jul 3, 2025 |
| May 13, 2025 | RLYB Rallybio Corp | AGrant or award Option (Right to Buy)derivative | +28,500 | $0.00 | $0 | 28,500 | May 15, 2025 |
| Jan 2, 2025 | RLYB Rallybio Corp | AGrant or award Option (Right to Buy)derivative | +73,571 | $0.70 | $51k | 73,571 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.